Cite

HARVARD Citation

    Enzenhofer, E. et al. (2017). Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines. Head & neck. 39 (5), pp. 900-907. [Online]. 
  
Back to record